🏛️ The Life-Saving Drug Dilemma

🌟 Imagine you need a cancer drug to survive, but it costs more than most people earn in a year. What happens when patent rights clash with the right to live? This episode explores one of India's most groundbreaking patent cases that changed everything.

💡 What You'll Discover:

• 🔍 Why being "new" isn't enough - patents need real-world usefulness too
• ⚖️ How courts can force companies to share life-saving inventions
• 🎯 The three pillars every patent must stand on: novelty, inventiveness, and utility
• 💊 Why importing drugs isn't the same as making them locally

🚀 Real Cases Discussed:

• 💎 Bayer Corporation vs Union of India (2014) - The landmark case where patient access beat patent profits
• ⭐ Natco Pharma's compulsory license battle - How a generic drug company took on Big Pharma and won

🎙️ This isn't just about legal theory - it's about the delicate balance between rewarding innovation and ensuring life-saving medicines reach those who need them most. You'll never look at patent law the same way again!